About the Company
We do not have any company description for Autonomix Medical, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Autonomix Medical, Inc.
Autonomix Medical, Inc. Finalizes Design Review of First-Ever Intravascular Nerve Sensing Catheter in Key Step Toward U.S. Clinical Studies
Microchip-based platform enables real-time nerve mapping and targeted treatment from within the vascular system Continued ...
Autonomix Medical, Inc. to Participate in Virtual Investor Webinar Hosted by Ladenburg Thalmann & Co. Inc.
PM ET Register here THE WOODLANDS, TX, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” ...
Autonomix Medical, Inc. Reports Second Quarter Fiscal Year 2025 ...
Autonomix Medical, Inc. Reports Second Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update News provided by Autonomix Medical, Inc. Nov 11, 2024, 8:00 AM ET ...
Autonomix Medical, Inc. Reports Third Quarter FY2024 Financial Results ...
THE WOODLANDS, TX, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative ...
Autonomix Medical, Inc. (AMIX) Upgraded to Strong Buy: Here's Why
Autonomix Medical, Inc. (AMIX) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings ...
Autonomix Medical, Inc. Reports First Quarter Fiscal Year 2025 ...
About Autonomix Medical, Inc. Autonomix is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated.
Autonomix Medical, Inc. Reports New Positive Topline Results from First ...
About Autonomix Medical, Inc. Autonomix is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated.
Autonomix Medical, Inc. Granted New U.S. Patent to Advance Minimally ...
News provided by Autonomix Medical, Inc. Jul 21, 2025, 8:45 AM ET With over 80 issued patents and 40 pending patent applications, Autonomix is building a comprehensive IP portfolio in nerve ...
Autonomix Medical, Inc. Granted New U.S. Patent to Advance ... - ABC27
News provided by Autonomix Medical, Inc. Jul 21, 2025, 8:45 AM ET With over 80 issued patents and 40 pending patent applications, Autonomix is building a comprehensive IP portfolio in nerve ...
Autonomix Medical, Inc. Reports New Positive Topline Results ... - Nasdaq
Autonomix Medical, Inc. Reports New Positive Topline Results from First 15 Patients’ 7-Day Data Highlighting Significant Impact on Treatment of Pancreatic Cancer Pain with Maintained Pain Reduction ...
Brad Hauser, CEO of Autonomix Medical, Inc. Outlines Follow-On ...
Brad Hauser, CEO of Autonomix Medical, Inc. Outlines Follow-On Expansion Study Expected to Begin in Q2 2025, Potentially Doubling Addressable Market Provided by GlobeNewswire May 13, 2025, 6:20:00 AM ...
Autonomix Medical, Inc. to Present Innovative Neural Ablation ...
Autonomix Medical, Inc. announced that its innovative technology and results from an early proof-of-concept study will be showcased in a poster presentation at EuroPCR 2025, the leading course in ...
Similar Companies
Loading the latest forecasts...